Nantahala Capital Management, LLC 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:51 pm Sale |
2023-12-31 | 13G | Aptose Biosciences Inc. APTO |
Nantahala Capital Management, LLC | 4,004 1.500% |
-197,758 (-98.02%) |
Filing |
| 2023-02-14 4:56 pm Sale |
2022-12-31 | 13G | Aptose Biosciences Inc. APTO |
Nantahala Capital Management, LLC | 13,451 6.600% |
-3,449 (-20.41%) |
Filing |
| 2022-02-14 08:03 am Purchase |
2021-12-31 | 13G | Aptose Biosciences Inc. APTO |
Nantahala Capital Management, LLC | 16,899 8.500% |
738 (+4.57%) |
Filing |
| 2021-02-12 3:25 pm Purchase |
2020-12-31 | 13G | Aptose Biosciences Inc. APTO |
Nantahala Capital Management, LLC | 16,161 8.200% |
2,709 (+20.13%) |
Filing |